Sandercock Brett 4
4 · RESMED INC · Filed Nov 4, 2025
Insider Transaction Report
Form 4
RESMED INCRMD
Sandercock Brett
Chief Financial Officer
Transactions
- Exercise/Conversion
ResMed Common Stock
2025-11-03$101.64/sh+2,000$203,280→ 88,745 total - Sale
ResMed Common Stock
2025-11-03$247.54/sh−3,000$742,620→ 85,745 total - Exercise/Conversion
ResMed Common Stock Options
2025-11-03−2,000→ 0 totalExercise: $101.64From: 2019-11-11Exp: 2025-11-14→ ResMed Common Stock (2,000 underlying)
Footnotes (2)
- [F1]The transaction was conducted under a Rule 10b5-1 plan adopted February 19, 2025.
- [F2]Represents date options first become exercisable. Options vest 1/3 per year.